'AstraZeneca's Obesity Pill Matches Rivals In Phase 2, Anchoring $5B Franchise Push; AstraZeneca Obesity Pill Helps Patients Lose 10.5% Of Body Weight In Trial' - Endpoints News

Benzinga Newsdesk www.benzinga.com Neutral 49.0%

Neg 0% Neu 49% Pos 0%

https://endpoints.news/ada26-astrazeneca-glp-1-pill-cuts-weight-10-5-after-six-months/

Comments

No comments yet. Be the first!